Patents by Inventor Todd M. Gierman

Todd M. Gierman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for detection of parvovirus B19
    Patent number: 9290820
    Abstract: Nucleic acid molecules derived from sequences of novel human parvovirus B19 variant genomes are provided. Also provided are assays and kits comprising the nucleic acid molecules.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: March 22, 2016
    Assignee: Grifols Therapeutics Inc.
    Inventors: Douglas C. Lee, Todd M. Gierman, Chris Glenn, Burton Beams, Brett Buno, Lori Rinckel
  • METHODS, NUCLEIC ACIDS, AND KITS FOR DETECTION OF PARVOVIRUS B19
    Publication number: 20140106337
    Abstract: Nucleic acid molecules derived from sequences of novel human parvovirus B19 variant genomes are provided. Also provided are assays and kits comprising the nucleic acid molecules.
    Type: Application
    Filed: October 14, 2013
    Publication date: April 17, 2014
    Applicant: GRIFOLS THERAPEUTICS INC.
    Inventors: DOUGLAS C. LEE, TODD M. GIERMAN, CHRIS GLENN, BURTON BEAMS, BRETT BUNO, LORI RINCKEL
  • Oligonucleotides and methods for detection of West Nile virus
    Patent number: 8609828
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: December 17, 2013
    Assignee: Bayer HealthCare LLC
    Inventors: Stefan H. M. Burde, Todd M. Gierman, Christopher C. Glenn
  • OLIGONUCLEOTIDES AND METHODS FOR DETECTION OF WEST NILE VIRUS
    Publication number: 20110008768
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Application
    Filed: July 30, 2010
    Publication date: January 13, 2011
    Applicant: Bayer HealthCare LLC
    Inventors: Stefan H.M. Burde, Todd M. Gierman, Christopher C. Glenn
  • Oligonucleotides and methods for detection of west nile virus
    Patent number: 7795417
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Grant
    Filed: November 6, 2007
    Date of Patent: September 14, 2010
    Assignee: Bayer HealthCare LLC
    Inventors: Stefan H. M. Burde, Todd M. Gierman, Christopher C. Glenn
  • Oligonucleotides and methods for detection of West Nile virus
    Patent number: 7385049
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: June 10, 2008
    Assignee: Bayer HealthCare LLC
    Inventors: Stefan H. M. Burde, Todd M. Gierman, Christopher C. Glenn
  • OLIGONUCLEOTIDES AND METHODS FOR DETECTION OF WEST NILE VIRUS
    Publication number: 20080131872
    Abstract: The invention provides methods of detecting West Nile virus and oligonucleotide reagents derived from a West Nile virus consensus sequence that are useful in the methods of the invention.
    Type: Application
    Filed: November 6, 2007
    Publication date: June 5, 2008
    Inventors: Stefan H. M. Burde, Todd M. Gierman